The above list of factors is not exhaustive The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income and gross margin, adjusted operating income, free cash flow, return on invested capital, GLS operating income, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations.

+View All Injection molding parameters, startup and shutdown, mold design and troubleshooting recommendations for Therma-Tech™ Thermally Conductive Formulations Gordon Glass™ Distributor List

Pune, India 4. Shanghai, China (3) Pune, India (1) 24. Pune, India 4.

This would allow Avient to remain modestly levered at 2.9x adjusted EBITDA while also expanding adjusted EBITDA margins from 12% to 18%, the highest amongst our formulator peers.” The above list of factors is not exhaustive. The non-GAAP financial measures include estimated 2022 Dyneema business and Composites Platform pro forma EBITDA.

The above list of factors is not exhaustive. We will uphold these values with the utmost integrity in all that we do. With over 100 Avient production and distribution facilities, all operating with the rigor of Lean Six Sigma principles and excellence, we are proud to serve our valued customers wherever they need us.

• The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations. Net debt $ 638.8 Adjusted EBITDA Q3 2012 Q4 2012 Q1 2013 Q2 2013 Total PolyOne Income before income taxes $ 30.6 $ (1.1) $ 15.7 $ 62.9 $ 108.1 PolyOne Interest expense, net 12.4 13.7 15.6 16.6 58.3 PolyOne Depreciation and amortization 17.0 15.5 19.0 25.8 77.3 PolyOne Special items in EBITDA 8.3 26.5 27.7 (5.2) 57.3 PolyOne Adjusted EBITDA 68.3 54.6 78.0 100.1 301.0 Pro forma Spartech EBITDA 16.8 14.7 11.2 - 42.7 Pro forma EBITDA $ 85.1 $ 69.3 $ 89.2 $ 100.1 $ 343.7 PolyOne Investor Presentation�Jefferies 2013 Global Industrials Conference��August 13, 2013� Forward – Looking Statements Use of Non GAAP Measures Strategy and Execution Drive Results Four Pillar Strategy PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth First Half 2013 Financial Highlights Debt Maturities & Liquidity Summary – 6/30/13 Use of Cash Why Invest In PolyOne?

• The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations. Net debt $ 638.8 Adjusted EBITDA Q3 2012 Q4 2012 Q1 2013 Q2 2013 Total PolyOne Income before income taxes $ 30.6 $ (1.1) $ 15.7 $ 62.9 $ 108.1 PolyOne Interest expense, net 12.4 13.7 15.6 16.6 58.3 PolyOne Depreciation and amortization 17.0 15.5 19.0 25.8 77.3 PolyOne Special items in EBITDA 8.3 26.5 27.7 (5.2) 57.3 PolyOne Adjusted EBITDA 68.3 54.6 78.0 100.1 301.0 Pro forma Spartech EBITDA 16.8 14.7 11.2 - 42.7 Pro forma EBITDA $ 85.1 $ 69.3 $ 89.2 $ 100.1 $ 343.7 PolyOne Investor Presentation�Credit Suisse 26th Annual Chemical and Ag Science Conference��September 17th, 2013� Forward – Looking Statements Use of Non-GAAP Measures Strategy and Execution Drive Results Four Pillar Strategy PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth First Half 2013 Financial Highlights Debt Maturities & Liquidity Summary – 6/30/13 Use of Cash Why Invest In PolyOne?

On a full year basis, we are maintaining our previous guidance of adjusted EBITDA and EPS of $530 million and $2.40. The non-GAAP financial measures include adjusted EPS, adjusted operating income, adjusted gross margin and adjusted EBITDA. The above list of factors is not exhaustive.

The above list of factors is not exhaustive. We will uphold these values with the utmost integrity in all that we do. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) 85 89 86 86 82 80 76 89 85 83 82 81 78 77 77 76 75 73 70 69 49 19 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is below specialty formulator peers and some of our more highly valued chemical peers.

The above list of factors is not exhaustive. We will uphold these values with the utmost integrity in all that we do. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 82% Median: 73% HIGH FREE CASH FLOW CONVERSION 83 86 85 85 80 78 58 88 83 81 79 77 76 73 73 72 72 67 64 63 60 Net Debt / 2021E EBITDA (1) We typically operate at 2.5–3.0x net debt to EBITDA.